drugset / Trial / NCT04139915
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine if RTB101 prevents illness associated with respiratory tract infections in people ≥65 years of age.
Timeline
- Start
- 2019-10-21
- Primary completion
- 2019-11-15
- Completion
- 2019-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dactolisib | Small molecule | 10 mg | Oral |